IMS Health (NYSE: RX) provides critical business intelligence, including information, analytics and consulting services to the pharmaceutical and healthcare industries worldwide.
IMS Health Incorporated is a global provider of market intelligence to the pharmaceutical and healthcare industries. They offer market intelligence products and services including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions. Their information products are developed to meet client needs by using data secured from a worldwide network of suppliers in more than 100 countries. Their business lines are:
- Commercial Effectiveness to increase clients’ productivity across end-to-end sales, marketing, promotional and performance management processes;
- Product and Portfolio Management to provide clients with insights into market measurement so they can optimize their product portfolio and strategies; and
- New Business Areas that support pharmaceutical client business initiatives in managed markets, consumer health, and pricing and market access, and that also serve payer and government audiences.
Within these business lines, they provide consulting and services that use in-house capabilities and methodologies to assist clients in analyzing and evaluating market trends, strategies and tactics, and to help in the development and implementation of customized software applications and data warehouse tools.
IMS Health operates in more than 100 countries.
Source: IMS Health May 1st, 2009 10-Q